4.7 Editorial Material

Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trials

Journal

LANCET ONCOLOGY
Volume 17, Issue 8, Pages 1037-1039

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(16)30017-1

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available